- Home
- ORIC vs NDMO Comparison
ORIC vs NDMO Comparison
Compare ORIC & NDMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- NDMO
- Stock Information
- Founded
- ORIC 2014
- NDMO 2019
- Country
- ORIC United States
- NDMO United States
- Employees
- ORIC N/A
- NDMO N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- NDMO Trusts Except Educational Religious and Charitable
- Sector
- ORIC Health Care
- NDMO Finance
- Exchange
- ORIC Nasdaq
- NDMO Nasdaq
- Market Cap
- ORIC 974.1M
- NDMO 620.6M
- IPO Year
- ORIC 2020
- NDMO N/A
- Fundamental
- Price
- ORIC $11.09
- NDMO $10.45
- Analyst Decision
- ORIC Strong Buy
- NDMO
- Analyst Count
- ORIC 10
- NDMO 0
- Target Price
- ORIC $17.33
- NDMO N/A
- AVG Volume (30 Days)
- ORIC 895.7K
- NDMO 218.6K
- Earning Date
- ORIC 11-11-2025
- NDMO 01-01-0001
- Dividend Yield
- ORIC N/A
- NDMO 6.75%
- EPS Growth
- ORIC N/A
- NDMO N/A
- EPS
- ORIC N/A
- NDMO N/A
- Revenue
- ORIC N/A
- NDMO N/A
- Revenue This Year
- ORIC N/A
- NDMO N/A
- Revenue Next Year
- ORIC N/A
- NDMO N/A
- P/E Ratio
- ORIC N/A
- NDMO N/A
- Revenue Growth
- ORIC N/A
- NDMO N/A
- 52 Week Low
- ORIC $3.90
- NDMO $8.99
- 52 Week High
- ORIC $14.67
- NDMO $11.24
- Technical
- Relative Strength Index (RSI)
- ORIC 60.61
- NDMO 74.98
- Support Level
- ORIC $10.37
- NDMO $10.36
- Resistance Level
- ORIC $11.16
- NDMO $9.98
- Average True Range (ATR)
- ORIC 0.50
- NDMO 0.11
- MACD
- ORIC 0.06
- NDMO 0.04
- Stochastic Oscillator
- ORIC 85.00
- NDMO 95.83
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About NDMO Nuveen Dynamic Municipal Opportunities Fund of Beneficial Interest
Nuveen Dynamic Municipal Opportunities is a closed-end management investment company. Its investment objective is to seek total return through income exempt from regular federal income taxes and capital appreciation. A majority of its investments are made in municipal securities, the income from which is exempted from regular federal income taxes.